Searched for
SME PHARMA COMPANIES
Time for long-term investors to look at them again? 9 NBFC stocks with upside potential of up to 22%The reason NBFC stocks reacted quickly to the easing of the US-Iran war risk is not difficult to understand. For a lender, macro relief tra...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- 20 months of bearish markets: One additional letter that tells you which 'cheap' stocks are actually cheapMost investors live by one ratio. That ratio that tells them all they want to know – or should one say all they want to hear? They open a s...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsFor the next few weeks, what needs to be watched is market breadth. And also look at which sectors are leading the rally. Why? Because, at ...
- MSMEs key to creating 20 lakh jobs in Andhra: Minister Nara LokeshThe government is promoting decentralized development through clusters and simplifying business processes. Plans are underway to list 100 A...
- Secular, cyclical or war-dependent: A ratio to tell you what kind of growth you are buying. 6 stocks with upside potential of up to 29%Some valuation ratios are used because they are easy. The PE ratio is one of them. It is simple, familiar, and convenient. Not only for the...
- IPO Calendar: 2 issues to keep investors busy but mainboard activity remains mutedIndia's primary market is set for a busy week with two SME IPOs. RFBL Flexi Pack and Goldline Pharmaceutical will open for subscription on ...
- How AI Innovation and Artificial Intelligence products are transforming global industriesAs innovation evolves beyond industry boundaries, the AI Special Product / Innovation category at the ET Most Innovative AI Product Awards ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%We are living in times when the morning may see conciliatory exchanges between the US and Iran, leading to a cooling in crude oil prices. B...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Bullish on power, energy, and BFSI; cautious on IT amid weak earnings: Devarsh VakilHDFC Securities sees opportunity in India's recovering equity markets. The firm favors power and energy sectors, citing infrastructure grow...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Speciality Medicines IPO: SME stock to list today. Check price band, other detailsSpeciality Medicines shares debut on the BSE SME platform today. The company's IPO, a fresh issue, sought to raise approximately Rs 29 cror...
- IPO Calendar: 3 new issues eye Rs 3,600 crore as primary market momentum continuesThree IPOs—Anthem Biosciences, Spunweb Nonwoven, and Monika Alcobev—aim to raise over Rs 3,600 crore in the week starting July 14. With str...
- Sudarshan Pharma withdraws SME IPO at the eleventh hourThe integrated chemical and pharma company was looking to raise Rs 25.80 crore.
- BSE SME platform to see 100 IPOs in 2018Funds raised through the issue will be used for business expansion plans, working capital requirements and other general corporate purposes.
- Small drug cos on anti-buyout driveConcerned about the recent spate of takeovers of domestic pharma firms by MNCs, small and medium players in the sector have decided to appr...
- Small drug firms to seek protectionConcerned about the recent spate of takeovers of domestic pharma firms by MNCs, small and medium players in the sector have decided to appr...
- SME pharmas likely to get interest sopsThe government may provide an interest subsidy to small and medium-size pharma companies to upgrade their facilities in order to meet strin...
- Big companies make hay from shining SMEsVishal Retail recently closed an initial public offer, which was oversubscribed 69%.
Load More
